Everand Logo

Welcome to Everand!

  • STAT

    Introducing the nominees for best biopharma CEO of 2017. Vote for your favorite!

    The criteria for determining the best biopharma CEO of 2017 was exceptionally high, which makes the nominees on this list all the more exceptional.
    by Adam Feuerstein Dec 11, 2017 2 minutes

    Biopharma has suffered some scares this year in Washington, D.C., and on Wall Street, but from a science perspective, the industry has performed admirably, particularly with big advances in cancer immunotherapy and gene therapy.

    I pored over spreadsheets, dug deep into medical journals, stared at stock charts, and consulted my beloved dog, Bo, to determine this year’s nominees for best biopharma CEO. There were some hard

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT1 min read
    STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
    Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
    STAT1 min read
    STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
    A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
    STAT2 min readCrime & Violence
    STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
    A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

    Related Books & Audiobooks